Vismodegib for treatment of periocular basal cell carcinoma - 6-year experience from a tertiary cancer center,

• Main Authors: Catarina Xavier (Author), Edgar Lopes (Author), Catarina Bexiga (Author), Cecília Moura (Author), Emanuel Gouveia (Author), Ana Filipa Duarte (Author)
• Format: Book
• Published: Sociedade Brasileira de Dermatologia, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background: The treatment of advanced periocular basal cell carcinomas becomes a challenge as surgery may involve highly mutilating procedures. Vismodegib is the first selective hedgehog inhibitor approved for the treatment of locally advanced tumors or metastatic disease. Objective: Analyz...